Pronóstico del mercado de diagnóstico de cáncer cerebral en América del Norte hasta 2028: impacto de COVID-19 y análisis regional por tipo de diagnóstico (prueba de imágenes, punción lumbar, biopsia, pruebas moleculares y otros); Tipo de cáncer (neuroma acústico, astrocitoma, craneofaringiomas, ganglioneuromas, glioblastoma multiforme, meningiomas, ependimomas y otros); Usuario final (hospitales, clínicas especializadas, centros de cirugía ambulatoria y otros)

Introducción al mercado

Los cánceres de cerebro se producen debido al crecimiento extracelular de las células del cerebro que causan los tumores. El tumor incluye tumores cerebrales primarios y tumores cerebrales secundarios. Los tumores cerebrales primarios se forman en el cerebro y no se diseminan a otras partes del cuerpo, mientras que los tumores secundarios, también conocidos como metástasis, son aquellos cánceres que comenzaron en otra parte del cuerpo. Los tumores cerebrales se clasifican en 40 tipos principales que a su vez se clasifican en dos grupos principales: benignos, es decir, de crecimiento lento y que tienen menos posibilidades de propagarse, y malignos, es decir, cancerosos y con mayor probabilidad de propagarse.

< p>Por lo tanto, se espera que el aumento de la prevalencia del cáncer de cerebro cree una demanda significativa de diagnósticos de cáncer de cerebro en los próximos años, lo que se prevé que impulse aún más el mercado de diagnóstico de cáncer de cerebro.

El COVID-19 La pandemia ha perturbado los sistemas de salud, generando preocupaciones sobre su impacto posterior en enfermedades no relacionadas con la COVID. El diagnóstico y el tratamiento del cáncer son urgentes y es probable que se vean afectados significativamente por estas condiciones. Las actividades de cada disciplina del cáncer se han visto afectadas negativamente por la pandemia de COVID-19. Además, los tumores cerebrales malignos infantiles se caracterizan por un rápido crecimiento y requieren un diagnóstico precoz y un tratamiento adecuado. Por tanto, retrasar o modificar el tratamiento puede comprometer su eficacia y reducir la supervivencia del paciente. Flores et al. informaron que el diagnóstico tardío de tumores cerebrales se correlaciona con un peor pronóstico. Un intervalo sintomático previo al diagnóstico prolongado tiene consecuencias negativas y graves, como la muerte o daño cerebral grave tras el aumento de la presión intracraneal. Debido al miedo y la presión de la infección por SARS CoV2, los cambios en el proceso de toma de decisiones de los niños con tumores cerebrales pueden tener un impacto negativo en su resultado final. Las juntas multidisciplinarias de tumores nunca han desempeñado un papel crucial durante el actual brote de COVID-19. Todos los casos pediátricos diagnosticados con un nuevo tumor cerebral deben discutirse en la junta multidisciplinaria de tumores para determinar el mejor plan de tratamiento para cada niño.

Descripción general y dinámica del mercado

Se espera que el mercado de diagnóstico de cáncer de cerebro en América del Norte crezca de 301,5 millones de dólares en 2021 a US$ 911,0 millones para 2028; se estima que crecerá a una tasa compuesta anual del 17,1% de 2021 a 2028. Los investigadores señalaron que la capacidad de la tecnología de inteligencia artificial y los patólogos para verificarse entre sí resalta la necesidad de que los patólogos cooperen con la tecnología de inteligencia artificial para interpretar casos desafiantes y garantizar la mayor precisión diagnóstica posible. Hoy en día, varios centros oncológicos importantes de EE. UU. utilizan generadores de imágenes SRH. Tanto la SRH como las imágenes de IA son tecnologías emergentes, por lo que integrarlas en la atención médica será un desafío. La tecnología de inteligencia artificial permite a los cirujanos identificar áreas que contienen tumores o tejido sano de manera rápida y precisa. Por lo tanto, la inteligencia artificial SRH se utiliza cada vez más para mejorar el diagnóstico de tumores cerebrales durante la cirugía.

Segmentos de mercado clave

En términos de tipo de diagnóstico, el segmento de pruebas de imágenes representó la mayor participación del mercado de diagnóstico de cáncer cerebral de América del Norte en 2020. En términos de tipo de cáncer, el segmento de glioblastoma multiforme representó la mayor participación del mercado de diagnóstico de cáncer de cerebro de América del Norte en 2020. En términos de usuario final, el segmento de hospitales representó la mayor participación del mercado de diagnóstico de cáncer de cerebro de América del Norte en 2020.

Principales fuentes y empresas incluidas

Algunas fuentes primarias y secundarias importantes Para preparar este informe sobre el mercado de diagnóstico del cáncer cerebral en América del Norte se hace referencia a los sitios web de las empresas, informes anuales, informes financieros, documentos del gobierno nacional y bases de datos estadísticas, entre otros. Las principales empresas que figuran en el informe son Thermo Fisher Scientific Inc., Siemens Healthineers A, GE Healthcare, MDxHealth, NantOmics, Biocept, Inc., Koninklijke Philips NV, Canon Medical Systems, Hitachi, Ltd. y Neusoft Medical Systems.

Informe de razones para comprar

Comprender el panorama del mercado de diagnóstico de cáncer de cerebro en América del Norte e identificar los segmentos del mercado que son más probablemente garantice un fuerte retorno
Manténgase a la vanguardia al comprender el panorama competitivo en constante cambio para el mercado de diagnóstico de cáncer cerebral de América del Norte
Planifique de manera eficiente fusiones y adquisiciones y acuerdos de asociación en el Norte Mercado de diagnóstico de cáncer de cerebro de América al identificar los segmentos de mercado con las ventas probables más prometedoras
Ayuda a tomar decisiones comerciales informadas a partir de un análisis perspicaz y completo del desempeño del mercado de varios segmentos del mercado de diagnóstico de cáncer de cerebro de América del Norte
Obtener una previsión de ingresos de mercado para varios segmentos entre 2021 y 2028 en la región de América del Norte.

Segmentación del mercado de diagnóstico de cáncer cerebral en América del Norte

Por tipo de diagnóstico

< ul>

Prueba de imágenes

Resonancia magnética
Tomografía computarizada
PET

Biopsia

Pruebas moleculares

Punción lumbar

Otros

Por tipo de cáncer

Glioblastoma multiforme
Astrocitomas
Ependimomas
Otros

Por Usuario final

Hospitales
Clínicas especializadas
Centros de cirugía ambulatoria
Otros

Por país

América del Norte
- EE.UU.
- Canadá
- México

Empresas mencionadas

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Brain Cancer Diagnostics Market – By Diagnostic Type

1.3.2 Brain Cancer Diagnostics Market – By Cancer Type

1.3.3 Brain Cancer Diagnostics Market – By End User

1.3.4 North America Brain Cancer Diagnostics Market – By Country

2. North America Brain Cancer Diagnostics Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Brain Cancer Diagnostics Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Brain Cancer Diagnostics Market- North America PEST Analysis

4.3 Expert Opinion

5. North America Brain Cancer Diagnostics Market - Key Market Dynamics

5.1 Market Drivers

5.1.1 Increase in Prevalence of Brain Cancer

5.1.2 Rise in Number of Cigarette Smokers

5.2 Market Restraints

5.2.1 High Cost of Diagnosis

5.3 Future Trends

5.3.1 Use of Stimulated Raman Histology (SRH)?Artificial Intelligence (AI) to Enhance Brain Tumor Diagnosis During Surgery

5.4 Impact Analysis

6. Brain Cancer Diagnostics Market – North America Analysis

6.1 North America Brain Cancer Diagnostics Market Revenue Forecasts and Analysis

7. North America Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Diagnostic Type

7.1 Overview

7.2 Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)

7.3 Imaging Tests

7.3.1 Overview

7.3.2 Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.3 MRI

7.3.3.1 Overview

7.3.3.2 MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.4 CT Scan

7.3.4.1 Overview

7.3.4.2 CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.5 Positron emission tomography (PET)

7.3.5.1 Overview

7.3.5.2 Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Lumbar Puncture

7.4.1 Overview

7.4.2 Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Biopsy

7.5.1 Overview

7.5.2 Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.6 Molecular Testing

7.6.1 Overview

7.6.2 Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.7 Others

7.7.1 Overview

7.7.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8. North America Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Cancer Type

8.1 Overview

8.2 Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)

8.3 Astrocytomas

8.3.1 Overview

8.3.2 Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Glioblastoma Multiforme

8.4.1 Overview

8.4.2 Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Ependymomas

8.5.1 Overview

8.5.2 Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Others

8.6.1 Overview

8.6.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9. Brain Cancer Diagnostics Market Analysis – By End user

9.1 Overview

9.2 Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Specialty Clinics

9.4.1 Overview

9.4.2 Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Ambulatory Surgical Centers

9.5.1 Overview

9.5.2 Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10. Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 – Geographical Analysis

10.1 North America: Brain Cancer Diagnostics Market

10.1.1 Overview

10.1.2 North America: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)

10.1.3 US: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.1 US: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.2 US Brain Cancer Diagnostics Market, by Diagnostic Type – Revenue and Forecast to 2028 (USD Million)

10.1.3.2.1 US Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

10.1.3.3 US Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

10.1.3.4 US Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.4 Canada: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.4.1 Canada: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.4.2 Canada Brain Cancer Diagnostics Market, by Diagnostic Type – Revenue and Forecast to 2028 (USD Million)

10.1.4.2.1 Canada Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

10.1.4.3 Canada Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

10.1.4.4 Canada Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.5 Mexico: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.5.1 Mexico: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.5.2 Mexico Brain Cancer Diagnostics Market, by Diagnostic Type – Revenue and Forecast to 2028 (USD Million)

10.1.5.2.1 Mexico Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

10.1.5.3 Mexico Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

10.1.5.4 Mexico Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

11. Impact Of COVID-19 Pandemic on North America Brain Cancer Diagnostics Market

11.1 North America: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

12.1 Overview

12.2 Growth Strategies Done by the Companies in the Market, (%)

12.1 Organic Developments

12.1.1 Overview

12.2 Inorganic Developments

12.2.1 Overview

13. Company Profiles

13.1 THERMO FISHER SCIENTIFIC INC.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Siemens Healthineers AG

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 GE Healthcare

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 MDxHealth

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 NantOmics

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Biocept, Inc.

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Koninklijke Philips N.V.

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Canon Medical Systems

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Hitachi, Ltd.

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Neusoft Medical Systems

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About the Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. US Brain Cancer Diagnostics Market, by Diagnostic Type – Revenue and Forecast to 2028 (USD Million)

Table 2. US Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

Table 3. US Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 4. US Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 5. Canada Brain Cancer Diagnostics Market, by Diagnostic Type - Revenue and Forecast to 2028 (USD Million)

Table 6. Canada Brain Cancer Diagnostics Market, by Imaging Test - Revenue and Forecast to 2028 (USD Million)

Table 7. Canada Brain Cancer Diagnostics Market, by Cancer Type - Revenue and Forecast to 2028 (USD Million)

Table 8. Canada Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 9. Mexico Brain Cancer Diagnostics Market, by Diagnostic Type – Revenue and Forecast to 2028 (USD Million)

Table 10. Mexico Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)

Table 11. Mexico Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 12. Mexico Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 13. Organic Developments in the Brain Cancer Diagnostics Market

Table 14. Inorganic Developments in the Brain Cancer Diagnostics Market

Table 15. Glossary of Terms, Brain Cancer Diagnostics Market

LIST OF FIGURES

Figure 1. Brain Cancer Diagnostics Market Segmentation

Figure 2. North America Brain Cancer Diagnostics Market Overview

Figure 3. Imaging Test Segment Held Largest Share of Diagnostic Type in Brain Cancer Diagnostics Market

Figure 4. US is Expected to Show Remarkable Growth During the Forecast Period

Figure 5. Brain Cancer Diagnostics Market - North America PEST Analysis

Figure 6. Brain Cancer Diagnostics Market Impact Analysis of Driver and Restraints

Figure 7. North America Brain cancer diagnostics Market – Revenue Forecasts and Analysis – 2020- 2028

Figure 8. Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)

Figure 9. Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10. MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11. CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)

Figure 18. Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)

Figure 23. Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. North America: Brain Cancer Diagnostics Market, by Key Country – Revenue (2021) (USD Million)

Figure 28. North America: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)

Figure 29. US: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 30. Canada: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 31. Mexico: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 32. Impact of COVID-19 Pandemic in North American Country Markets

Figure 33. Growth Strategies Done by the Companies in the Market, (%)

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America brain cancer diagnostics market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the North America brain cancer diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the brain cancer diagnostics market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
North America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a..	May 2022
North America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Ele..	May 2022
North America Cabinet LED Lighting Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (In-cabinet Lighting and Under-Cabinet Ligh..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample